About Index Trending news
Analyze
Top 50 Pricing
Viveve

Viveve

Viveve

Viveve develops non-surgical treatment for women who have experienced vaginallooseness and loss of physical sensation.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$15,500,000
Venture capital
$7,210,000
Employees

Unknown size

Locations
HQ
$15,500,000 Post-IPO equity
MassDevice

Viveve closes $16m uplisting